
    
      The aim of this study will assess the effects of intravenous immunoglobulin in ANCA+
      vasculitides (Microscopic Polyangiitis, Wegener's granulomatosis and Churg-Strauss syndrome)
      who relapse under corticosteroid and immunosuppressant therapies or after one year post
      treatment.
    
  